Changes in the RANK ligand/osteoprotegerin system are correlated to changes in bone mineral density in bisphosphonate-treated osteoporotic patients (Q46910500)

From Wikidata

Jump to navigation Jump to search

scientific article published on 25 January 2006

Language	Label	Description	Also known as
English	Changes in the RANK ligand/osteoprotegerin system are correlated to changes in bone mineral density in bisphosphonate-treated osteoporotic patients	scientific article published on 25 January 2006

Statements

scholarly article

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16435076

Changes in the RANK ligand/osteoprotegerin system are correlated to changes in bone mineral density in bisphosphonate-treated osteoporotic patients (English)

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16435076

0 references

author name string

H Dobnig

1

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16435076

L C Hofbauer

2

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16435076

V Viereck

3

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16435076

B Obermayer-Pietsch

4

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16435076

A Fahrleitner-Pammer

5

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16435076

language of work or name

0 references

publication date

25 January 2006

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16435076

Osteoporosis International

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16435076

17

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16435076

693-703

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16435076

5

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16435076

https://scigraph.springernature.com/pub.10.1007/s00198-005-0035-4

0 references

Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bisphosphonates: an overview with special reference to alendronate

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteoblast proliferation and maturation by bisphosphonates

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alendronate stimulation of nocturnal parathyroid hormone secretion: a mechanism to explain the continued improvement in bone mineral density accompanying alendronate therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteoprotegerin serum levels in women: correlation with age, bone mass, bone turnover and fracture status.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bisphosphonates pamidronate and zoledronic acid stimulate osteoprotegerin production by primary human osteoblasts.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biochemical markers as predictors of rates of bone loss after menopause

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical evaluation of the Serum CrossLaps One Step ELISA, a new assay measuring the serum concentration of bone-derived degradation products of type I collagen C-telopeptides.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased RANKL/OPG mRNA ratio in iliac bone biopsies from women with hip fractures.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Associations of serum osteoprotegerin levels with diabetes, stroke, bone density, fractures, and mortality in elderly women

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-mediated resorption

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of osteoblasts in hormonal control of bone resorption—A hypothesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of long-term risedronate on bone quality and bone turnover in women with postmenopausal osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The diagnosis of osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Circulating osteoprotegerin and receptor activator of NF-kappaB ligand system are associated with bone metabolism in middle-aged males

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum osteoprotegerin and its relationship with bone mineral density and markers of bone turnover.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-alpha converting enzyme (TACE).

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Skeletal changes in osteoprotegerin and receptor activator of nuclear factor-kappab ligand mRNA levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The contribution of serum osteoprotegerin to bone mass and vertebral fractures in postmenopausal women

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteoprotegerin serum levels in men: correlation with age, estrogen, and testosterone status

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bisphosphonates act on rat bone resorption through the mediation of osteoblasts

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vertebral fracture assessment using a semiquantitative technique.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The OPG/RANKL/RANK system in metabolic bone diseases.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High levels of osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor alpha treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monitoring of Alendronate Treatment and Prediction of Effect on Bone Mass by Biochemical Markers in the Early Postmenopausal Intervention Cohort Study1

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteoblast behaviour in the presence of bisphosphonates: ultrastructural and biochemical in vitro studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bisphosphonates stimulate formation of osteoblast precursors and mineralized nodules in murine and human bone marrow cultures in vitro and promote early osteoblastogenesis in young and aged mice in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bisphosphonates inhibit IL-6 production by human osteoblast-like cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-response relationships for alendronate treatment in osteoporotic elderly women. Alendronate Elderly Osteoporosis Study Centers

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Etidronate inhibits the production of IL-6 by osteoblast-like cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/16435076

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00198-005-0035-4

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16435076

1 reference

Europe PubMed Central

26 December 2017

http://europepmc.org/abstract/MED/16435076

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46910500&oldid=2137598434"